Skinae

Skinae is a South Korean biotechnology company specializing in the development of exosome-based therapeutics for dermatological conditions and aesthetic medicine. The company utilizes its proprietary Exo-Skin platform to isolate and engineer high-purity exosomes derived from various cell sources to target inflammatory and regenerative pathways. Its primary pipeline focuses include treatments for atopic dermatitis and alopecia, alongside a portfolio of medical aesthetic products. Skinae aims to bridge the gap between advanced cell-free therapy and clinical dermatology through its specialized delivery and stabilization technologies. The company's approach emphasizes safety and efficacy by utilizing the natural signaling capabilities of exosomes to promote tissue repair and immune modulation.